March 10, 2022: Trehalose Mechanism of Action & Science

Sabrina Paganoni, MD, PhD, scientists from Seelos Therapeutics, and regimen co-leads Merit Cudkowicz, MD, MSc and Shafeeq Ladha, MD presented the rationale and science behind trehalose, the investigational product being studied in Regimen E of the HEALEY ALS Platform Trial, and answered questions from the audience.